Washington Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,500
Closed -$645K 123
2025
Q1
$645K Sell
7,500
-1,000
-12% -$82K 0.52% 52
2024
Q4
$664K Hold
8,500
0.52% 48
2024
Q3
$613K Hold
8,500
0.47% 57
2024
Q2
$585K Hold
8,500
0.5% 61
2024
Q1
$617K Hold
8,500
0.5% 59
2023
Q4
$520K Buy
+8,500
New +$505K 0.45% 74
2018
Q2
Sell
-12,750
Closed -$430K 106
2018
Q1
$430K Buy
12,750
+1,700
+15% +$65.2K 0.43% 68
2017
Q4
$491K Buy
11,050
+3,050
+38% +$139K 0.49% 49
2017
Q3
$401K Hold
8,000
0.43% 74
2017
Q2
$422K Hold
8,000
0.47% 54
2017
Q1
$444K Buy
8,000
+2,600
+48% +$143K 0.52% 55
2016
Q4
$281K Buy
+5,400
New +$261K 0.35% 82
2016
Q3
Sell
-7,000
Closed -$388K 89
2016
Q2
$388K Sell
7,000
-29,501
-81% -$1.63M 0.55% 59
2016
Q1
$1.95M Sell
36,501
-1,681
-4% -$82.8K 1.43% 20
2015
Q4
$1.97M Sell
38,182
-349
-0.9% -$17.3K 1.22% 27
2015
Q3
$1.74M Buy
38,531
+1,455
+4% +$68.7K 1.09% 39
2015
Q2
$1.71M Hold
37,076
0.96% 41
2015
Q1
$1.59M Sell
37,076
-31,995
-46% -$1.22M 0.91% 47
2014
Q4
$2.4M Sell
69,071
-10,129
-13% -$336K 1% 47
2014
Q3
$2.56M Sell
79,200
-1,135
-1% -$38K 1.01% 35
2014
Q2
$2.72M Sell
80,335
-1,343
-2% -$43K 1% 19
2014
Q1
$2.23M Sell
81,678
-60,428
-43% -$1.8M 0.8% 53
2013
Q4
$5.09M Buy
142,106
+3,441
+2% +$114K 1.23% 14
2013
Q3
$4.18M Sell
138,665
-7,892
-5% -$258K 1.11% 17
2013
Q2
$4.27M Buy
+146,557
New +$4.13M 1.11% 16

Other funds holding PBH

Washington Capital Management's PBH Position: Q2 2025 in Review

Washington Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2025, closing a stake of 7,500 shares — an estimated $645K sold.

Washington Capital Management first reported a position in PBH in Q2 2013 and held it in 25 quarters. The position peaked at $5.09M in Q4 2013. 378 funds tracked by Wall St. Rank hold PBH as of Q2 2025.

  • Washington Capital Management reported no remaining Prestige Consumer Healthcare position as of Q2 2025 after selling out during the quarter.
  • Washington Capital Management sold 7,500 Prestige Consumer Healthcare shares in Q2 2025, an estimated $645K.
  • Washington Capital Management first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 25 quarters.
  • Washington Capital Management's Prestige Consumer Healthcare position peaked at $5.09M in Q4 2013.
  • 378 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2025.

Based on Washington Capital Management's 13F filing for Q2 2025, filed 17 Jul 2025.